Back to Search Results- Recruiting
- Observational
- Other & Procedure
- University of Washington
- 40 Years -
Study Purpose
This study investigates ways to detect prostate cancer earlier in people at genetic risk for disease that forms, grows, or spreads quickly (aggressive). Studying samples of blood, urine, and/or tissue in the laboratory may help doctors further understand the genetics of prostate cancer and help identify ways to detect cancer earlier, thereby improving treatment and methods of early detection in the future.
Intervention
Procedure : Biospecimen Collection
Other : Laboratory Biomarker Analysis
Other : Quality-of-Life Assessment
Other : Questionnaire Administration
Eligibility Requirements
People with prostates ≥40 years of age
Documented germline pathogenic variant in known or suspected genes associated with prostate cancer risk.
Prior diagnosis of prostate cancer
Medical contraindication to any of the study procedures (e.g., prostate biopsy)
For all cancer types except non-melanoma skin cancer, any cancer treatment with curative intent within the past 12 months (e.g., surgery, radiation, chemotherapy, immunotherapy)
Prior or concurrent participation in an interventional clinical trial aimed at preventing cancer for people with germline variants associated with increased prostate cancer risk
Unable to provide written informed consent
Unable or unwilling to complete clinical care and study procedures as indicated by the study protocol.
Recruiting status
Recruiting
Estimated enrollment
450
Study start date
May 21, 2020
Study end date
Aug 31, 2030
Last updated
Mar 24, 2025
Primary purpose
N/A
Design
Observational
Intervention
Other & Procedure
Study phase
N/A
Allocation
N/A
Sponsor:
University of Washington
Collaborator:
National Cancer Institute (NCI)
Canary Foundation
CureBRCA
Investigator:
Heather H. Cheng, MD, PhD
N/A
Publications
N/A
Websites
N/A
NCT04472338
| Clinic | Location | Investigator | Distance | RECRUITING STATUS | Contact |
|---|